Literature DB >> 15007126

Motor hand representation in cortical area 44.

Takenori Uozumi1, A Tamagawa, T Hashimoto, S Tsuji.   

Abstract

OBJECTIVE: To elucidate whether area 44 of human frontal cortex is essential for the organization of voluntary hand movements or not, the authors examined effects of single transcranial magnetic stimulation (TMS) of human area 44 on voluntary hand movement and electromyography (EMG) activities in hand muscles.
METHOD: Surface EMG responses were recorded from the thenar muscles of 10 normal subjects following TMS over area 44. Stimuli were applied 2 cm anterior to the primary tongue motor area.
RESULTS: Single TMS over area 44 could easily interrupt target-oriented hand movements. Human area 44 has facilitatory and inhibitory effects over both tonic and phasic finger movements. It is shown that single TMS of area 44 produces motor evoked potential from hand muscles.
CONCLUSION: Human area 44 is involved in voluntary hand movements and has direct fast-conducting corticospinal projections.

Entities:  

Mesh:

Year:  2004        PMID: 15007126     DOI: 10.1212/01.wnl.0000113731.75479.25

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Corticospinal output and cortical excitation-inhibition balance in distal hand muscle representations in nonprimary motor area.

Authors:  Selja Vaalto; Laura Säisänen; Mervi Könönen; Petro Julkunen; Taina Hukkanen; Sara Määttä; Jari Karhu
Journal:  Hum Brain Mapp       Date:  2010-09-30       Impact factor: 5.038

Review 2.  Apollo's gift: new aspects of neurologic music therapy.

Authors:  Eckart Altenmüller; Gottfried Schlaug
Journal:  Prog Brain Res       Date:  2015-02-11       Impact factor: 2.453

3.  From Singing to Speaking: Why Singing May Lead to Recovery of Expressive Language Function in Patients with Broca's Aphasia.

Authors:  Gottfried Schlaug; Sarah Marchina; Andrea Norton
Journal:  Music Percept       Date:  2008-04-01

4.  Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial.

Authors:  Kevin A Johnson; Mirza Baig; Dave Ramsey; Sarah H Lisanby; David Avery; William M McDonald; Xingbao Li; Elisabeth R Bernhardt; David R Haynor; Paul E Holtzheimer; Harold A Sackeim; Mark S George; Ziad Nahas
Journal:  Brain Stimul       Date:  2012-03-14       Impact factor: 8.955

5.  From singing to speaking: facilitating recovery from nonfluent aphasia.

Authors:  Gottfried Schlaug; Andrea Norton; Sarah Marchina; Lauryn Zipse; Catherine Y Wan
Journal:  Future Neurol       Date:  2010-09

6.  Evidence for plasticity in white-matter tracts of patients with chronic Broca's aphasia undergoing intense intonation-based speech therapy.

Authors:  Gottfried Schlaug; Sarah Marchina; Andrea Norton
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

7.  Auditory-motor mapping training as an intervention to facilitate speech output in non-verbal children with autism: a proof of concept study.

Authors:  Catherine Y Wan; Loes Bazen; Rebecca Baars; Amanda Libenson; Lauryn Zipse; Jennifer Zuk; Andrea Norton; Gottfried Schlaug
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

8.  Auditory-Motor Mapping Training: Comparing the Effects of a Novel Speech Treatment to a Control Treatment for Minimally Verbal Children with Autism.

Authors:  Karen Chenausky; Andrea Norton; Helen Tager-Flusberg; Gottfried Schlaug
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

9.  Detection of motor execution using a hybrid fNIRS-biosignal BCI: a feasibility study.

Authors:  Raphael Zimmermann; Laura Marchal-Crespo; Janis Edelmann; Olivier Lambercy; Marie-Christine Fluet; Robert Riener; Martin Wolf; Roger Gassert
Journal:  J Neuroeng Rehabil       Date:  2013-01-21       Impact factor: 4.262

10.  Corticospinal excitability modulation during action observation.

Authors:  Luisa Sartori; Sonia Betti; Umberto Castiello
Journal:  J Vis Exp       Date:  2013-12-31       Impact factor: 1.355

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.